The FDA has issued Emergency Use Authorization (EUA) for Abbott’s BinaxNOW rapid antigen test for detection of COVID-19 infection. The $5 test is highly portable, affordable and provides results in 15 minutes. It uses proven Abbott lateral flow technology, making it a reliable and familiar format for frequent mass testing by healthcare providers. Abbott will ship […]

Takeda has entered into an agreement to divest Takeda Consumer Healthcare Company (TCHC), a wholly-owned subsidiary of Takeda focused on the consumer health care market primarily in Japan, to a company controlled by funds managed by The Blackstone Group for a total value of 2.3 billion USD. The transaction is expected to close by March […]

The FDA has approved Foundation Medicine’s comprehensive pan-tumor liquid biopsy test, Called FoundationOne Liquid CDx. Using a blood sample, the test analyzes over 300 cancer-related genes for alterations. Results are delivered in an integrated report that identifies alterations matched to FDA-approved therapies and delivers information about the genomic signatures microsatellite instability and blood tumor mutational […]

Momenta Pharmaceuticals has agreed to be acquired by Johnson & Johnson for $52.50 per share in an all-cash transaction, implying a fully-diluted equity value of $6.5 billion. The agreement was unanimously approved by the Boards of Directors of both Momenta and Johnson & Johnson. “The agreement with J&J recognizes the value created by years of […]

Sanofi and San Francisco-based Principia Biopharma have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash, which represents an aggregate equity value of approximately $3.68 billion (on a fully diluted basis). Principia Biopharma is a late-stage biopharma focused on developing treatments […]